Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005

NCT00161811 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1400

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Vero Cell-derived Influenza Vaccine
BIOLOGICAL: Egg cell-derived Influenza Vaccine

Sponsor

Alachua Government Services, Inc.